UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

Lancet neurology, 2017-08, Vol.16 (8), p.601-609

2017

Volltextzugriff (PDF)

CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes

Current biology, 2015-09, Vol.25 (18), p.2411-2416

2015

Volltextzugriff (PDF)

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease

PloS one, 2016-09, Vol.11 (9), p.e0163479-e0163479

2016

Volltextzugriff (PDF)

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease

PloS one, 2020-08, Vol.15 (8), p.e0233820

2020

Volltextzugriff (PDF)

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease

Science translational medicine, 2018-09, Vol.10 (458)

2018

Volltextzugriff (PDF)

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease

Science translational medicine, 2020-12, Vol.12 (574)

2020

Volltextzugriff (PDF)

A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease

Genome medicine, 2023-07, Vol.15 (1), p.50-50, Article 50

2023

Volltextzugriff (PDF)

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children

Movement disorders, 2022-07, Vol.37 (7), p.1526-1531

2022

Volltextzugriff (PDF)

Neurofilament light protein in blood predicts regional atrophy in Huntington disease

Neurology, 2018-02, Vol.90 (8), p.e717

2018

Volltextzugriff (PDF)

Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study

Scientific reports, 2022-11, Vol.12 (1), p.18377-18377, Article 18377

2022

Volltextzugriff (PDF)

Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease

The Journal of neuroscience, 2021-01, Vol.41 (4), p.780-796

2021

Volltextzugriff (PDF)

Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization

The Journal of clinical investigation, 2021-06, Vol.131 (12), p.1-15

2021

Volltextzugriff (PDF)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease

Journal of neurochemistry, 2021-07, Vol.158 (2), p.539-553

2021

Volltextzugriff (PDF)

A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study

Journal of medical Internet research, 2022-06, Vol.24 (6), p.e32997-e32997

2022

Volltextzugriff (PDF)

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease

Scientific reports, 2021-02, Vol.11 (1), p.3481-3481, Article 3481

2021

Volltextzugriff (PDF)

Amplitude Integrated Electroencephalography: Simulated Assessment of Neonatal Seizure Detection in PICU Patients

Pediatric critical care medicine, 2023-12, Vol.24 (12), p.e627-e634

2023

Volltextzugriff (PDF)

Cerebrospinal Fluid Biomarkers for Huntington's Disease

Journal of Huntington's disease, 2016-01, Vol.5 (1), p.1-13

2016

Volltextzugriff (PDF)

A pilot study of a novel, incentivised mHealth technology to monitor the vaccine supply chain in rural Zambia

The Pan African medical journal, 2019, Vol.33 (50), p.50-50

2019

Volltextzugriff (PDF)

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease

Scientific reports, 2018-03, Vol.8 (1), p.4260-7, Article 4260

2018

Volltextzugriff (PDF)

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice

Translational neurodegeneration, 2024-10, Vol.13 (1), p.50-22, Article 50

2024

Volltextzugriff (PDF)

How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky

Addiction science & clinical practice, 2024-11, Vol.19 (1), p.1-13, Article 78

2024

Volltextzugriff (PDF)

Clinical Review of Juvenile Huntington's Disease

Journal of Huntington's disease, 2024-01, Vol.13 (2), p.149-161

2024

Volltextzugriff (PDF)

Relationships Between the ACGME Resident and Faculty Surveys and Program Pass Rates on the ABIM Internal Medicine Certification Examination

Academic medicine, 2018-08, Vol.93 (8), p.1205-1211

2018

Volltextzugriff (PDF)

Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI

The European journal of neuroscience, 2019-06, Vol.49 (12), p.1632-1639

2019

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(246)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(316)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis

CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes

Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease

Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease

A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children

Neurofilament light protein in blood predicts regional atrophy in Huntington disease

Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study

Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease

Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease

A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease

Amplitude Integrated Electroencephalography: Simulated Assessment of Neonatal Seizure Detection in PICU Patients

Cerebrospinal Fluid Biomarkers for Huntington's Disease

A pilot study of a novel, incentivised mHealth technology to monitor the vaccine supply chain in rural Zambia

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice

How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky

Clinical Review of Juvenile Huntington's Disease

Relationships Between the ACGME Resident and Faculty Surveys and Program Pass Rates on the ABIM Internal Medicine Certification Examination

Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI

Suchergebnisse filtern